Capraro L
Finnish Red Cross Blood Transfusion Service, Helsinki, Finland.
Vox Sang. 1998;75(1):1-6.
A multicenter survey was carried out in 11 Finnish hospitals to determine the prevailing transfusion practices in orthopedic surgery.
The records of 1,161 patients who had undergone primary total hip (THR) or knee replacement (TKR) were reviewed.
Allogeneic red cells (RBC) were administered to 92% of the THR patients and to 84% of the patients undergoing TKR. Significant interhospital variation in RBC transfusion, from 2.4 to 4.1 units per patient in THR and from 1.8 to 2.8 units in TKR, was detected after adjustment for clinical and laboratory findings.
The use of RBCs in orthopedic surgery was generous compared with reports from other European countries and the US. Each hospital's individual transfusion policy seemed to be a strong determinant of allogeneic blood use.
在芬兰的11家医院开展了一项多中心调查，以确定骨科手术中普遍存在的输血实践。
回顾了1161例行初次全髋关节置换术（THR）或全膝关节置换术（TKR）患者的记录。
92%的THR患者和84%的TKR患者接受了异体红细胞（RBC）输注。在对临床和实验室检查结果进行校正后，发现不同医院间RBC输注存在显著差异，THR患者每位输注2.4至4.1单位，TKR患者每位输注1.8至2.8单位。
与其他欧洲国家和美国的报告相比，骨科手术中RBC的使用量较大。每家医院的个体输血政策似乎是异体血使用的一个重要决定因素。
